Warning: The NCBI web site requires JavaScript to function. more...
GSK-3beta phosphorylation of functionally distinct tau isoforms has differential, but mild effects.
Voss K, Gamblin TC.
Mol Neurodegener. 2009 May 2;4:18.
Related citations
Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I, Barrachina M, Puig B.
Acta Neuropathol. 2002 Dec;104(6):583-91. Epub 2002 Jul 13.
Pseudohyperphosphorylation has differential effects on polymerization and function of tau isoforms.
Combs B, Voss K, Gamblin TC.
Biochemistry. 2011 Nov 8;50(44):9446-56. Epub 2011 Oct 17.
Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease.
Buée L, Delacourte A.
Brain Pathol. 1999 Oct;9(4):681-93. Review.
Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter.
Zhukareva V, Mann D, Pickering-Brown S, Uryu K, Shuck T, Shah K, Grossman M, Miller BL, Hulette CM, Feinstein SC, Trojanowski JQ, Lee VM.
Ann Neurol. 2002 Jun;51(6):730-9.
Three repeat isoforms of tau inhibit assembly of four repeat tau filaments.
Adams SJ, DeTure MA, McBride M, Dickson DW, Petrucelli L.
PLoS One. 2010 May 25;5(5):e10810.
Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities.
Mailliot C, Bussière T, Hamdane M, Sergeant N, Caillet ML, Delacourte A, Buée L.
Ann N Y Acad Sci. 2000;920:107-14.
Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.
Yoshida M.
Neuropathology. 2006 Oct;26(5):457-70.
Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.
Mailliot C, Sergeant N, Bussière T, Caillet-Boudin ML, Delacourte A, Buée L.
FEBS Lett. 1998 Aug 21;433(3):201-4.
Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms.
Tolnay M, Sergeant N, Ghestem A, Chalbot S, De Vos RA, Jansen Steur EN, Probst A, Delacourte A.
Acta Neuropathol. 2002 Oct;104(4):425-34. Epub 2002 Jul 26.
Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35. Implications for Alzheimer's disease.
Hernández F, Pérez M, Lucas JJ, Mata AM, Bhat R, Avila J.
J Biol Chem. 2004 Jan 30;279(5):3801-6. Epub 2003 Nov 5.
Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M, Ramasamy K, Russ C, Freeman SH, Orne J, Raju S, Matsui T, Growdon JH, Frosch MP, Ghetti B, Brown RH, Irizarry MC, Hyman BT.
Acta Neuropathol. 2007 Nov;114(5):471-9. Epub 2007 Aug 25.
Tau exon 10 alternative splicing and tauopathies.
Liu F, Gong CX.
Mol Neurodegener. 2008 Jul 10;3:8.
Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo JM, Hanger D, Mulot S, Marquardt B, Stabel S, et al.
Curr Biol. 1994 Dec 1;4(12):1077-86.
Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly.
Utton MA, Vandecandelaere A, Wagner U, Reynolds CH, Gibb GM, Miller CC, Bayley PM, Anderton BH.
Biochem J. 1997 May 1;323 ( Pt 3):741-7.
Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
Spillantini MG, Van Swieten JC, Goedert M.
Neurogenetics. 2000 Mar;2(4):193-205. Review.
Three- and four-repeat Tau coassemble into heterogeneous filaments: an implication for Alzheimer disease.
Siddiqua A, Margittai M.
J Biol Chem. 2010 Nov 26;285(48):37920-6. Epub 2010 Oct 4.
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ, Grundke-Iqbal I, Iqbal K.
Eur J Neurosci. 2007 Jan;25(1):59-68.
Tau and saitohin gene expression pattern in progressive supranuclear palsy.
Ezquerra M, Gaig C, Ascaso C, Muñoz E, Tolosa E.
Brain Res. 2007 May 11;1145:168-76. Epub 2007 Feb 1.
Glycogen synthase kinase-3β2 has lower phosphorylation activity to tau than glycogen synthase kinase-3β1.
Saeki K, Machida M, Kinoshita Y, Takasawa R, Tanuma S.
Biol Pharm Bull. 2011;34(1):146-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on